2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine
Keywords
Single nucleotide polymorphism
Haplotype
2′,5′-Oligoadenylate synthetase
Rubella vaccine
Immunity
Cited by (0)
Dr. Poland is the chair of a DMSB for novel non-rubella vaccines undergoing clinical study by Merck Research Laboratories. Dr. Jacobson serves on a Safety Review Committee for a post-licensure study of Gardasil for Kaiser-Permanente.
Copyright © 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.